News/ Sales and Marketing Biogen protects Tecfidera via $1.25bn deal with Forward Richard Staines Biogen, Forward Pharma, Intellectual property, multiple sclerosis, patent, Tecfidera 0 Comment Biogen could also pay royalties to Forward. Share X Biogen protects Tecfidera via $1.25bn deal with Forward https://pharmaphorum.com/news/biogen-protects-tecfidera-1-25bn-deal-forward/